Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Gross Profit | Gross Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 61.63M | 94.7% | $ 65.08M |
3/31/2025 | $ 178.69M | 99.47% | $ 179.64M |
12/31/2024 | $ 177.96M | 99.96% | $ 178.03M |
9/30/2024 | $ 175.04M | 100% | $ 175.04M |
6/30/2024 | $ 141.46M | 100% | $ 141.46M |
3/31/2024 | $ 18.36M | 100% | $ 18.36M |
12/31/2023 | $ 60.28M | 100% | $ 60.28M |
9/30/2023 | $ 71.08M | 100% | $ 71.08M |
6/30/2023 | $ 70.77M | 100% | $ 70.77M |
3/31/2023 | $ 71.17M | 100% | $ 71.17M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Revenues
(=) Gross %
Gross % for ADAPTIMMUNE THERAPEUTICS PLC is calculated as follows: GP [ $ 3.18M ] / Revenues [ $ 3.18M ]
(=) Gross % [ 100% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.81K |
---|---|
min | -72.25% |
max | 150.26% |
average | 53.09% |
median | 49.46% |
std | 31.59% |